Teladoc Health, Inc.TDOCNYSE
LOADING
|||
Switch Symbol:
Operating Income Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
4.46%
↑ 101% above average
Average (39q)
-605.20%
Historical baseline
Range
High:97.98%
Low:-15998.33%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 4.46% |
| Q2 2025 | 54.91% |
| Q1 2025 | -150.15% |
| Q4 2024 | -8.59% |
| Q3 2024 | 94.72% |
| Q2 2024 | -865.48% |
| Q1 2024 | -148.35% |
| Q4 2023 | 45.80% |
| Q3 2023 | 9.66% |
| Q2 2023 | 7.08% |
| Q1 2023 | 97.98% |
| Q4 2022 | -5219.33% |
| Q3 2022 | 97.68% |
| Q2 2022 | 53.57% |
| Q1 2022 | -15998.33% |
| Q4 2021 | 31.61% |
| Q3 2021 | 23.27% |
| Q2 2021 | 6.77% |
| Q1 2021 | 81.53% |
| Q4 2020 | -2224.49% |
| Q3 2020 | -174.76% |
| Q2 2020 | 65.83% |
| Q1 2020 | -34.79% |
| Q4 2019 | 21.84% |
| Q3 2019 | 9.44% |
| Q2 2019 | 3.78% |
| Q1 2019 | -28.31% |
| Q4 2018 | -13.05% |
| Q3 2018 | 13.05% |
| Q2 2018 | 4.95% |
| Q1 2018 | 22.26% |
| Q4 2017 | -14.01% |
| Q3 2017 | -48.64% |
| Q2 2017 | 2.09% |
| Q1 2017 | -11.88% |
| Q4 2016 | 34.69% |
| Q3 2016 | -40.07% |
| Q2 2016 | 1.72% |
| Q1 2016 | -2.57% |
| Q4 2015 | -13.90% |